Glenmark Initiates Phase-3 Clinical Trials For Favipiravir To Treat COVID-19
Posted by
www.biotecnika.org
The Phase-3 trials of an antiviral drug, Favipiravir, has been
initiated by Glenmark Pharmaceuticals. India's drug regulator DCGI had
approved the drug in late April. Glenmark Pharmaceuticals is the first
drug manufacturer in India to initiate Phase-3 clinical trials on
Favipiravir for treating COVID-19 patients. Favipiravir is an
antiviral medication under the brand name Avigan […]
The post Glenmark Initiates Phase-3 Clinical Trials For Favipiravir To
Treat COVID-19 appeared first on Rasayanika .
https://www.rasayanika.com/2020/05/13/phase-3-trials-of-favipiravir-by-glenmark-initiated-for-treating-covid-19/
News
Subscribe to:
Post Comments (Atom)
Post a Comment